Shanghai Junshi Biosciences in human tests for coronavirus antibody drug
BEIJING (Reuters) – Shanghai Junshi Biosciences has started an early-stage study in China to test a potential antibody treatment against…
Swiss coronavirus cases surge, canton orders seniors to stay home
ZURICH (Reuters) – Switzerland on Saturday reported 6,100 coronavirus infections, 25% more than a day earlier, and 56 deaths, the…
Trudeau self-isolates as wife is tested for coronavirus
OTTAWA (Reuters) – Canadian Prime Minister Justin Trudeau and his wife Sophie are in self-isolation after she came down with…
Canada’s Trudeau self-isolates as wife is tested for coronavirus
FILE PHOTO: Canada’s Prime Minister Justin Trudeau and his wife Sophie Gregoire Trudeau hold white roses as they attend a…
Biogen scraps development of therapy for rare brain disease
(Reuters) – Biogen Inc said on Friday it would discontinue the development of its experimental therapy for a rare brain…
Sarepta shares surge after surprise approval of Duchenne Muscular Dystrophy drug
(Reuters) – Shares of Sarepta Therapeutics Inc (SRPT.O) soared 36% on Friday after U.S. regulators shocked Wall Street by approving…
U.S. FDA gives early approval to Sarepta’s newest DMD treatment
FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4,…
Adamis shares slump as FDA declines to approve opioid overdose treatment
(Reuters) – Adamis Pharmaceuticals Corp (ADMP.O) said on Monday the U.S. Food and Drug Administration declined to approve its opioid…
CymaBay Therapeutics scraps two studies of liver drug; shares plunge
(Reuters) – CymaBay Therapeutics Inc said on Monday it was scrapping two mid-stage trials of its liver disease drug, after…
FDA approves Global Blood Therapeutics sickle cell disease drug
(Reuters) – The U.S. Food and Drug Administration said on Monday it approved a drug from Global Blood Therapeutics Inc…
U.S. heart patients cut back on life-saving drugs due to cost
(Reuters Health) – One in eight adults with heart disease delays filling prescriptions. takes less of the medication than prescribed,…
FDA approves Aquestive’s ALS treatment
(Reuters) – The U.S. Food and Drug Administration on Friday approved bit.ly/2pIFzi5 Aquestive Therapeutics’ treatment for neurological disorder amyotrophic lateral…
Roche drug for spinal muscular atrophy hits target in late-stage trial
ZURICH (Reuters) – Roche’s bid to rival Biogen and Novartis in treating spinal muscular atrophy (SMA) got a lift on…
U.S. sanctions on Iran threaten access to certain medicines: report
WASHINGTON (Reuters) – U.S. sanctions on Iran threaten access by some Iranians to medicines that treat diseases such as cancer…
Johnson & Johnson says baby powder investigation could take 30 days or more
(Reuters) – Johnson & Johnson said on Friday its investigation into asbestos contamination of its baby powder could take 30…
FDA approves Alexion’s Ultomiris for another rare blood disease
(Reuters) – The U.S. Food and Drug Administration on Friday approved Alexion Pharmaceuticals Inc’s treatment for a second rare blood…
Sacklers reaped up to $13 billion from OxyContin maker, U.S. states say
(Reuters) – OxyContin maker Purdue Pharma LP steered up to $13 billion in profits to the company’s controlling Sackler family,…
CVS drug coverage plan based on outside pricing review is off to a slow start
NEW YORK (Reuters) – A CVS Health Corp (CVS.N) health plan that uses an outside drug pricing group to help…
CVS suspends sales of Zantac brand and generic heartburn drug during safety review
People walk by a CVS Pharmacy store in the Manhattan borough of New York City, New York, U.S., November 30,…
U.S. House speaker: Drug pricing plan should be priority for White House
WASHINGTON (Reuters) – House Democrats’ plan to help lower the cost of medicines should be a priority for the White…
Novo Nordisk to cut insulin prices in the U.S.
COPENHAGEN (Reuters) – Novo Nordisk will offer cheaper insulin to U.S. diabetics, the Danish drugmaker said on Friday, in response…
Drugmakers file second court challenge to Canada’s new drug price rules
TORONTO (Reuters) – Canada’s main pharmaceutical industry lobby group, along with 16 of its member companies, filed a lawsuit on…
FDA approves Boehringer’s lung disease drug
(Reuters) – The U.S. Food and Drug Administration on Friday approved German drugmaker Boehringer Ingelheim’s Ofev capsules for a rare…
U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta
(Reuters) – The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of…
Trump presses U.S. companies to close China operations
WASHINGTON (Reuters) – President Donald Trump said on Friday he was ordering U.S. companies to look at ways to close…
Companies file suit in Canada challenging new rules to lower drug prices
(Reuters) – Five pharmaceutical companies said on Friday they have filed a complaint in a Canadian court challenging the constitutionality…
Trump administration to appeal ruling blocking price disclosure for drug ads
FILE PHOTO: Bottles of drugs sit on the shelf at the Rock Canyon Pharmacy, in Provo, Utah, U.S., May 9,…
Cardinal Health warns ongoing opioid-related lawsuits to hit business
(Reuters) – Drug distributor Cardinal Health Inc (CAH.N) warned on Tuesday that its business could be hurt as it defends…
FDA declines to approve Sarepta’s second Duchenne treatment
(Reuters) – Sarepta Therapeutics Inc said on Monday the U.S. Food and Drug Administration declined to approve its newest treatment…
AbbVie prices new rheumatoid arthritis drug at $59,000 a year
(Reuters) – AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on…
AbbVie prices new rheumatoid arthritis drug at $59,000/yr
(Reuters) – AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on…
U.S. records 10 new cases of measles last week
FILE PHOTO: A vial of the measles, mumps, and rubella (MMR) vaccine is pictured at the International Community Health Services…
Regeneron’s Ebola treatment proves superior to rival in trial
(Reuters) – Regeneron Pharmaceuticals Inc said on Monday its experimental treatment for Ebola proved superior to a rival therapy from…
Sarepta says adverse event report for DMD gene therapy erroneously submitted
(Reuters) – Sarepta Therapeutics Inc said on Thursday it was informed that an adverse event report was erroneously submitted to…
Drug industry urges Canada to act early on U.S. import plan
TORONTO (Reuters) – Canada’s main pharmaceutical lobby group has urged the government not to wait for drug shortages before responding…
Trump administration considers September unveiling of healthcare plan: WSJ
FILE PHOTO: U.S. President Donald Trump arrives at Morristown municipal airport for a weekend at the Trump National Golf Club…
Trump firms up plan to import medicines; pharma companies resist
(Reuters) – The Trump administration took a step Wednesday toward allowing importation of medicines from Canada, an action the president…
Bernie Sanders visits Canadian pharmacy, talks drug prices
WINDSOR, Ontario (Reuters) – U.S. Senator and Democratic presidential hopeful Bernie Sanders joined diabetes patients as they drove across the…
European panel okays GW Pharma cannabis drug for epilepsy
(Reuters) – GW Pharmaceuticals’ marijuana-based treatment Epidyolex has won a positive recommendation for marketing approval from a European Medicines Agency…
Novartis’s older MS drug Gilenya wins Chinese approval
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland…
Exclusive: Canada warns U.S. against drug import plans, citing shortage concerns
TORONTO (Reuters) – Canada opposes any U.S. plans to buy Canadian prescription drugs that might threaten the country’s drug supply…
Indivior says Reckitt settlement in U.S. unrelated to its cases
(Reuters) – Drugmaker Indivior Plc said on Thursday its former parent Reckitt Benckiser’s $1.4 billion settlement with authorities in the…
Reckitt to pay $1.4 billion to end U.S. opioid addiction treatment probes
(Reuters) – Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals…
Reckitt to pay $1.4 billion to end U.S. opioid addiction treatment probes
(Reuters) – Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals…
CannTrust slumps after Health Canada finds unlicensed pot cultivation
(Reuters) – CannTrust Holdings Inc’s shares plunged about 23% to a more than one-and-half-year low on Monday, after Health Canada…
Novartis to sell epinephrine shot in U.S. pharmacies amid EpiPen shortage
(Reuters) – Novartis AG (NOVN.S) said on Tuesday it would make its generic pre-filled epinephrine shots immediately available in local…
Novartis to sell epinephrine injector in U.S. pharmacies amid EpiPen shortage
FILE PHOTO: EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen…
FDA ties three deaths to Edwards Lifesciences’ recalled heart devices
(Reuters) – The U.S. Food and Drug Administration said on Monday three deaths had been reported related to Edwards Lifesciences…
FDA declines to approve Daiichi Sankyo’s blood cancer treatment
(Reuters) – Japan’s Daiichi Sankyo Co said on Friday the U.S. Food and Drug Administration has declined to approve its…
Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma
(Reuters) – Pfizer Inc on Monday said it would buy Array Biopharma Inc for $10.64 billion in cash, a deal…
GSK pharma head flags need for speed in high-pressure drug market
LONDON (Reuters) – Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford…
VBI’s shares plunge after hep B vaccine fails secondary goal in late-stage trial
(Reuters) – VBI Vaccines Inc said on Monday a late-stage study was unsuccessful in showing two doses of its hepatitis…
Enanta’s lung infection therapy succeeds in mid-stage trial
(Reuters) – Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal…
Pharmacies may not stock naloxone, despite statewide orders
(Reuters Health) – More than three years after Pennsylvania issued a statewide order expanding access to the life-saving opioid antidote…
Canadian panel calls for universal public drug coverage
OTTAWA/TORONTO (Reuters) – A Canadian advisory council studying prescription drug coverage said on Wednesday the federal government should create a…
Co-owner, ex-employee of pharmacy in U.S. meningitis outbreak acquitted
BOSTON (Reuters) – A federal judge on Friday tossed the convictions of a co-owner and former employee of a Massachusetts…
British Columbia to be first Canadian province to switch patients to biosimilars
TORONTO/MONTREAL (Reuters) – The Canadian province of British Columbia said on Monday that its public drug plan will switch as…
Novartis CEO plans gene therapy price ‘far lower’ than $4 million to $5 million range
FILE PHOTO: The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017.…
U.S. states accuse Teva, other drugmakers, of price-fixing: lawsuit
WASHINGTON (Reuters) – U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19…
U.S. states accuse Teva, other drugmakers, of price-fixing: lawsuit
WASHINGTON (Reuters) – U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19…